» Articles » PMID: 30573743

β-N-methylamino-L-alanine (BMAA) Suppresses Cell Cycle Progression of Non-neuronal Cells

Overview
Journal Sci Rep
Specialty Science
Date 2018 Dec 22
PMID 30573743
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

β-N-methylamino-L-alanine (BMAA), a natural non-proteinaceous amino acid, is a neurotoxin produced by a wide range of cyanobacteria living in various environments. BMAA is a candidate environmental risk factor for neurodegenerative diseases such as amyotrophic lateral sclerosis and Parkinson-dementia complex. Although BMAA is known to exhibit weak neuronal excitotoxicity via glutamate receptors, the underlying mechanism of toxicity has yet to be fully elucidated. To examine the glutamate receptor-independent toxicity of BMAA, we investigated the effects of BMAA in non-neuronal cell lines. BMAA potently suppressed the cell cycle progression of NIH3T3 cells at the G1/S checkpoint without inducing plasma membrane damage, apoptosis, or overproduction of reactive oxygen species, which were previously reported for neurons and neuroblastoma cells treated with BMAA. We found no evidence that activation of glutamate receptors was involved in the suppression of the G1/S transition by BMAA. Our results indicate that BMAA affects cellular functions, such as the division of non-neuronal cells, through glutamate receptor-independent mechanisms.

Citing Articles

Freshwater Cyanobacterial Toxins, Cyanopeptides and Neurodegenerative Diseases.

Nugumanova G, Ponomarev E, Askarova S, Fasler-Kan E, Barteneva N Toxins (Basel). 2023; 15(3).

PMID: 36977124 PMC: 10057253. DOI: 10.3390/toxins15030233.


Motor dysfunction in as a biomarker for developmental neurotoxicity.

Cabrita A, Medeiros A, Pereira T, Rodrigues A, Kranendonk M, Mendes C iScience. 2022; 25(7):104541.

PMID: 35769875 PMC: 9234254. DOI: 10.1016/j.isci.2022.104541.


Cyanobacteria, Cyanotoxins, and Neurodegenerative Diseases: .

Sini P, Dang T, Fais M, Galioto M, Padedda B, Luglie A Int J Mol Sci. 2021; 22(16).

PMID: 34445429 PMC: 8395864. DOI: 10.3390/ijms22168726.

References
1.
Spencer P, Roy D, Ludolph A, Hugon J, DWIVEDI M, Schaumburg H . Lathyrism: evidence for role of the neuroexcitatory aminoacid BOAA. Lancet. 1986; 2(8515):1066-7. DOI: 10.1016/s0140-6736(86)90468-x. View

2.
Jonasson S, Eriksson J, Berntzon L, Spacil Z, Ilag L, Ronnevi L . Transfer of a cyanobacterial neurotoxin within a temperate aquatic ecosystem suggests pathways for human exposure. Proc Natl Acad Sci U S A. 2010; 107(20):9252-7. PMC: 2889067. DOI: 10.1073/pnas.0914417107. View

3.
Wang H, Joseph J . Quantifying cellular oxidative stress by dichlorofluorescein assay using microplate reader. Free Radic Biol Med. 1999; 27(5-6):612-6. DOI: 10.1016/s0891-5849(99)00107-0. View

4.
Rao S, Banack S, Cox P, Weiss J . BMAA selectively injures motor neurons via AMPA/kainate receptor activation. Exp Neurol. 2006; 201(1):244-52. DOI: 10.1016/j.expneurol.2006.04.017. View

5.
Anzilotti S, Brancaccio P, Simeone G, Valsecchi V, Vinciguerra A, Secondo A . Preconditioning, induced by sub-toxic dose of the neurotoxin L-BMAA, delays ALS progression in mice and prevents Na/Ca exchanger 3 downregulation. Cell Death Dis. 2018; 9(2):206. PMC: 5833681. DOI: 10.1038/s41419-017-0227-9. View